Martin Torriani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Martin Torriani has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Bijoy J. Thomas
Division of Musculoskeletal Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
2 shared publications- Chelsea Pan
Department of Medicine, University of California, San Francisco, San Francisco, California, USA
1 shared publication - Colleen Hadigan
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
1 shared publication Daniel I. Rosenthal
Division of Musculoskeletal Radiology, Department of Radiology, Massachusetts General Hospital, 15 Parkman St., WACC 515, Boston, MA 02114
1 shared publication- David E. Kleiner
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, USA
1 shared publication Eliane Maria Ingrid Amstalden
1 shared publication
Latest Publications
- Open Access
- 20 August 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (16)
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
Nonalcoholic fatty liver disease (NAFLD) is a common comorbidity among people living with HIV that has a more aggressive course than NAFLD among the general population. In a recent randomized placebo-controlled trial, we demonstrated that the growth hormone–releasing hormone analog tesamorelin reduced liver fat and prevented fibrosis progression in HIV-associated NAFLD over 1 year. As such, tesamorelin is the first strategy that has shown to be effective against NAFLD among the population with HIV. The current study leveraged paired liver biopsy specimens from this trial to identify hepatic gene pathways that are differentially modulated by tesamorelin versus placebo. Using gene set enrichment analysis, we found that tesamorelin increased hepatic expression of hallmark gene sets involved in oxidative phosphorylation and decreased hepatic expression of gene sets contributing to inflammation, tissue repair, and cell division. Tesamorelin also reciprocally up- and downregulated curated gene sets associated with favorable and poor hepatocellular carcinoma prognosis, respectively. Notably, among tesamorelin-treated participants, these changes in hepatic expression correlated with improved fibrosis-related gene score. Our findings inform our knowledge of the biology of pulsatile growth hormone action and provide a mechanistic basis for the observed clinical effects of tesamorelin on the liver.
- 20 August 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (16)
Open AccessEffects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
Nonalcoholic fatty liver disease (NAFLD) is a common comorbidity among people living with HIV that has a more aggressive course than NAFLD among the general population. In a recent randomized placebo-controlled trial, we demonstrated that the growth hormone–releasing hormone analog tesamorelin reduced liver fat and prevented fibrosis progression in HIV-associated NAFLD over 1 year. As such, tesamorelin is the first strategy that has shown to be effective against NAFLD among the population with HIV. The current study leveraged paired liver biopsy specimens from this trial to identify hepatic gene pathways that are differentially modulated by tesamorelin versus placebo. Using gene set enrichment analysis, we found that tesamorelin increased hepatic expression of hallmark gene sets involved in oxidative phosphorylation and decreased hepatic expression of gene sets contributing to inflammation, tissue repair, and cell division. Tesamorelin also reciprocally up- and downregulated curated gene sets associated with favorable and poor hepatocellular carcinoma prognosis, respectively. Notably, among tesamorelin-treated participants, these changes in hepatic expression correlated with improved fibrosis-related gene score. Our findings inform our knowledge of the biology of pulsatile growth hormone action and provide a mechanistic basis for the observed clinical effects of tesamorelin on the liver.
- 30 September 2007
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 25 (7) , 1105-1111
Intramyocellular lipid quantification: comparison between 3.0- and 1.5-T 1H-MRS
- 30 September 2007
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 25 (7) , 1105-1111
Intramyocellular lipid quantification: comparison between 3.0- and 1.5-T 1H-MRS
- 1 February 2006
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 100 (2) , 609-614
Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution
The human immunodeficiency virus (HIV)-lipodystrophy syndrome is associated with fat redistribution and metabolic abnormalities, including insulin resistance. Increased intramyocellular lipid (IMCL) concentrations are thought to contribute to insulin resistance, being linked to metabolic and body composition variables. We examined 46 women: HIV infected with fat redistribution ( n = 25), and age- and body mass index-matched HIV-negative controls ( n = 21). IMCL was measured by1H-magnetic resonance spectroscopy, and body composition was assessed with computed tomography, dual-energy X-ray absorptiometry (DEXA), and magnetic resonance imaging. Plasma lipid profile and markers of glucose homeostasis were obtained. IMCL was significantly increased in tibialis anterior [135.0 ± 11.5 vs. 85.1 ± 13.2 institutional units (IU); P = 0.007] and soleus [643.7 ± 61.0 vs. 443.6 ± 47.2 IU, P = 0.017] of HIV-infected subjects compared with controls. Among HIV-infected subjects, calf subcutaneous fat area (17.8 ± 2.3 vs. 35.0 ± 2.5 cm2, P < 0.0001) and extremity fat by DEXA (11.8 ± 1.1 vs. 15.6 ± 1.2 kg, P = 0.024) were reduced, whereas visceral abdominal fat (125.2 ± 11.3 vs. 74.4 ± 12.3 cm2, P = 0.004), triglycerides (131.1 ± 11.0 vs. 66.3 ± 12.3 mg/dl, P = 0.0003), and fasting insulin (10.8 ± 0.9 vs. 7.0 ± 0.9 μIU/ml, P = 0.004) were increased compared with control subjects. Triglycerides ( r = 0.39, P = 0.05) and extremity fat as percentage of whole body fat by DEXA ( r = −0.51, P = 0.01) correlated significantly with IMCL in the HIV but not the control group. Extremity fat (β = −633.53, P = 0.03) remained significantly associated with IMCL among HIV-infected patients, controlling for visceral abdominal fat, abdominal subcutaneous fat, and antiretroviral medications in a regression model. These data demonstrate increased IMCL in HIV-infected women with a mixed lipodystrophy pattern, being most significantly associated with reduced extremity fat. Further studies are necessary to determine the relationship between extremity fat loss and increased IMCL in HIV-infected women.
- 1 February 2006
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 100 (2) , 609-614
Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution
The human immunodeficiency virus (HIV)-lipodystrophy syndrome is associated with fat redistribution and metabolic abnormalities, including insulin resistance. Increased intramyocellular lipid (IMCL) concentrations are thought to contribute to insulin resistance, being linked to metabolic and body composition variables. We examined 46 women: HIV infected with fat redistribution ( n = 25), and age- and body mass index-matched HIV-negative controls ( n = 21). IMCL was measured by1H-magnetic resonance spectroscopy, and body composition was assessed with computed tomography, dual-energy X-ray absorptiometry (DEXA), and magnetic resonance imaging. Plasma lipid profile and markers of glucose homeostasis were obtained. IMCL was significantly increased in tibialis anterior [135.0 ± 11.5 vs. 85.1 ± 13.2 institutional units (IU); P = 0.007] and soleus [643.7 ± 61.0 vs. 443.6 ± 47.2 IU, P = 0.017] of HIV-infected subjects compared with controls. Among HIV-infected subjects, calf subcutaneous fat area (17.8 ± 2.3 vs. 35.0 ± 2.5 cm2, P < 0.0001) and extremity fat by DEXA (11.8 ± 1.1 vs. 15.6 ± 1.2 kg, P = 0.024) were reduced, whereas visceral abdominal fat (125.2 ± 11.3 vs. 74.4 ± 12.3 cm2, P = 0.004), triglycerides (131.1 ± 11.0 vs. 66.3 ± 12.3 mg/dl, P = 0.0003), and fasting insulin (10.8 ± 0.9 vs. 7.0 ± 0.9 μIU/ml, P = 0.004) were increased compared with control subjects. Triglycerides ( r = 0.39, P = 0.05) and extremity fat as percentage of whole body fat by DEXA ( r = −0.51, P = 0.01) correlated significantly with IMCL in the HIV but not the control group. Extremity fat (β = −633.53, P = 0.03) remained significantly associated with IMCL among HIV-infected patients, controlling for visceral abdominal fat, abdominal subcutaneous fat, and antiretroviral medications in a regression model. These data demonstrate increased IMCL in HIV-infected women with a mixed lipodystrophy pattern, being most significantly associated with reduced extremity fat. Further studies are necessary to determine the relationship between extremity fat loss and increased IMCL in HIV-infected women.
- 1 February 2003
- Published by Wolters Kluwer Health in Topics in Magnetic Resonance Imaging
- Vol. 14 (1) , 103-111
Musculoskeletal Ultrasound: An Alternative Imaging Modality for Sports-Related Injuries
Advanced technology and increasing clinical experience have established sonography as a reliable imaging modality for sports-related injuries. Tears of muscles and tendons, tendinosis, and tenosynovitis are promptly diagnosed using ultrasound. Dynamic assessment of joints can be performed, allowing diagnoses of conditions that may remain undetected when evaluated with conventional magnetic resonance imaging. Sonography provides expeditious image guidance for procedures such as drainage of fluid collections and cysts. This article reviews the applications of sonography to sports-related injuries in which its diagnostic performance may be comparable to magnetic resonance imaging.
- 1 February 2003
- Published by Wolters Kluwer Health in Topics in Magnetic Resonance Imaging
- Vol. 14 (1) , 103-111
Musculoskeletal Ultrasound: An Alternative Imaging Modality for Sports-Related Injuries
Advanced technology and increasing clinical experience have established sonography as a reliable imaging modality for sports-related injuries. Tears of muscles and tendons, tendinosis, and tenosynovitis are promptly diagnosed using ultrasound. Dynamic assessment of joints can be performed, allowing diagnoses of conditions that may remain undetected when evaluated with conventional magnetic resonance imaging. Sonography provides expeditious image guidance for procedures such as drainage of fluid collections and cysts. This article reviews the applications of sonography to sports-related injuries in which its diagnostic performance may be comparable to magnetic resonance imaging.
- 1 September 2002
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 26 (5) , 855-859
Magnetic Resonance Imaging of Tibial Classic Adamantinoma at 2 Tesla
Adamantinoma is a rare malignant neoplasm arising most often in the tibia and is locally aggressive. Conservative surgical treatment frequently is followed by recurrence and magnetic resonance (MR) imaging plays an important role in preoperative planning. Magnetic resonance features of this tumor have not been described in detail. We report three cases of classic tibial adamantinoma examined at 2 Tesla. High-resolution images with findings that may influence management are discussed.
- 1 September 2002
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 26 (5) , 855-859
Magnetic Resonance Imaging of Tibial Classic Adamantinoma at 2 Tesla
Adamantinoma is a rare malignant neoplasm arising most often in the tibia and is locally aggressive. Conservative surgical treatment frequently is followed by recurrence and magnetic resonance (MR) imaging plays an important role in preoperative planning. Magnetic resonance features of this tumor have not been described in detail. We report three cases of classic tibial adamantinoma examined at 2 Tesla. High-resolution images with findings that may influence management are discussed.
- 21 June 2002
- Published by Springer Nature in Pediatric Radiology
- Vol. 32 (8) , 615-618
Percutaneous radiofrequency treatment of osteoid osteoma
Osteoid osteoma is a small osteogenic tumor usually found in the lower extremity of children and young adults. Although these lesions are benign and rarely progress, they present distinctive pain symptoms that frequently require medical intervention. This article reviews surgical, medical, and percutaneous techniques for treatment of osteoid osteoma, emphasizing the value of percutaneous radiofrequency treatment.
- 21 June 2002
- Published by Springer Nature in Pediatric Radiology
- Vol. 32 (8) , 615-618
Percutaneous radiofrequency treatment of osteoid osteoma
Osteoid osteoma is a small osteogenic tumor usually found in the lower extremity of children and young adults. Although these lesions are benign and rarely progress, they present distinctive pain symptoms that frequently require medical intervention. This article reviews surgical, medical, and percutaneous techniques for treatment of osteoid osteoma, emphasizing the value of percutaneous radiofrequency treatment.